Here's the live share price of Norris Medicines along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Norris Medicines | 1.81 | -3.50 | -1.46 | -15.30 | -28.37 | 6.14 | 12.05 |
| Sun Pharmaceutical Industries | 0.77 | -2.64 | -1.52 | 0.16 | 6.54 | 22.17 | 21.55 |
| Divi's Laboratories | 0.78 | 0.47 | 6.35 | 3.86 | -0.71 | 24.76 | 8.76 |
| Torrent Pharmaceuticals | 5.08 | 6.00 | 4.46 | 22.53 | 42.41 | 36.86 | 25.50 |
| Cipla | -0.87 | 7.47 | 4.77 | -8.48 | -7.56 | 13.10 | 7.30 |
| Zydus Lifesciences | 2.14 | 19.49 | 21.34 | 19.71 | 13.65 | 29.69 | 11.17 |
| Dr. Reddy's Laboratories | -0.22 | 0.39 | -3.31 | -0.36 | -6.46 | 10.90 | 3.15 |
| Lupin | 0.32 | 1.31 | -3.46 | 7.63 | 12.52 | 40.61 | 13.81 |
| Mankind Pharma | 3.04 | 1.28 | 9.04 | 10.48 | 0.88 | 17.75 | 11.08 |
| Aurobindo Pharma | 1.02 | -0.76 | 12.50 | 23.77 | 27.91 | 30.58 | 8.24 |
| Laurus Labs | -3.06 | 10.48 | 34.13 | 38.22 | 110.54 | 59.83 | 17.68 |
| Biocon | 1.63 | 4.13 | 6.63 | 8.30 | 18.83 | 20.53 | 0.33 |
| Alkem Laboratories | 1.71 | -2.91 | -1.96 | -5.15 | 10.25 | 16.86 | 10.56 |
| Glenmark Pharmaceuticals | -0.99 | -4.95 | -5.05 | 8.61 | 30.91 | 49.75 | 27.21 |
| Abbott India | 0.32 | -2.97 | -2.23 | -6.65 | -17.08 | 5.98 | 9.92 |
| Anthem Biosciences | 2.68 | -2.24 | 22.19 | 11.91 | 7.12 | 2.32 | 1.39 |
| Ipca Laboratories | -1.71 | 6.82 | 3.56 | 10.08 | 16.75 | 30.26 | 9.05 |
| Ajanta Pharma | 5.37 | 1.51 | 0.49 | 17.94 | 14.98 | 29.77 | 19.41 |
| Gland Pharma | 1.53 | 23.23 | 39.27 | 37.34 | 38.42 | 34.24 | -6.04 |
| J B Chemicals & Pharmaceuticals | 5.27 | 7.03 | 7.14 | 26.88 | 30.88 | 28.78 | 24.19 |
Source: Dion Global
Over the last one year, Norris Medicines has declined 28.37% compared to peers like Sun Pharmaceutical Industries (6.54%), Divi's Laboratories (-0.71%), Torrent Pharmaceuticals (42.41%). From a 5 year perspective, Norris Medicines has outperformed peers relative to Sun Pharmaceutical Industries (21.55%) and Divi's Laboratories (8.76%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 13.88 | 13.74 |
| 10 | 13.71 | 13.71 |
| 20 | 13.49 | 13.7 |
| 50 | 13.92 | 13.85 |
| 100 | 13.93 | 14.18 |
| 200 | 15 | 14.93 |
Source: Dion Global
In the latest quarter, Norris Medicines saw a rise in promoter holding to 34.00%, while DII stake unchanged at 0.07%, FII holding unchanged at 0.00%, and public shareholding moved down to 65.90% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| May 30, 2026, 10:16 PM IST IST | Norris Medicines - Announcement under Regulation 30 (LODR)-Change in Management |
| May 30, 2026, 09:56 PM IST IST | Norris Medicines - Outcome Of Board Meeting Held Today I.E. 30Th May, 2026. |
| May 30, 2026, 09:48 PM IST IST | Norris Medicines - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 30Th May, 2026. |
| May 26, 2026, 01:10 AM IST IST | Norris Medicines - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Req |
| Apr 20, 2026, 05:38 AM IST IST | Norris Medicines - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Source: Dion Global
Norris Medicines Ltd. is a Public Limited Listed company incorporated on 07/09/1990 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1990PLC086581 and registration number is 086581. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 8.13 Cr. and Equity Capital is Rs. 9.93 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Norris Medicines is ₹13.51 as on Jun 11, 2026.
The Norris Medicines is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Norris Medicines is ₹13.51 Cr as on Jun 11, 2026.
Today’s highest and lowest price of Norris Medicines are ₹14.25 and ₹13.51.
The 52-week high/low is the highest and lowest price at which Norris Medicines stock has traded in the past 52-week or nearly a year. The 52-week high of Norris Medicines is ₹20.00 and 52-week low of Norris Medicines is ₹12.00 as on Jun 11, 2026.
The Norris Medicines has shown returns of -3.5% over the past day, -3.5% for the past month, -1.46% over 3 months, -28.37% over 1 year, 6.14% across 3 years, and 12.05% over 5 years.
P/E ratio of and PB ratio of Norris Medicines are -48.25 and -0.90 on Jun 11, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global